Christian Heiss։ When Diabetes and PAD Overlap, Cardiovascular and Limb Risks Rise
Christian Heiss, Associate Head of Medical School (Research and Innovation) at University of Surrey, Professor and NHS Consultant in Interventional Cardiovascular Medicine, shared a post on LinkedIn about a recent article by James Amamoo et al, published in American Journal of Preventive Cardiology:
”New paper worth flagging (Am J Prev Cardiol): in real-world data, people with type 2 diabetes who also have peripheral artery disease (PAD) had markedly higher risks of major adverse cardiovascular events (MACE) and major adverse limb events (MALE) than those without PAD.
It’s also a reminder that PAD remains under-recognised—most diagnostic work-ups still rely on ABI and duplex ultrasound.”
Title: Impact of peripheral artery disease (PAD) on risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes
Authors: James Amamoo, Lin Xie, Andrea Steffens, Erin Buysman, Caroline Swift, Sherif Mehanna, Noelle N. Gronroos, Marc P. Bonaca
Read the Full Article on American Journal of Preventive Cardiology
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events